These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20503409)

  • 1. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.
    Wu M; Wu ZF; Rosenthal DT; Rhee EM; Merajver SD
    Cancer; 2010 Jun; 116(11 Suppl):2768-82. PubMed ID: 20503409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
    Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
    Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC.
    Kitzing TM; Wang Y; Pertz O; Copeland JW; Grosse R
    Oncogene; 2010 Apr; 29(16):2441-8. PubMed ID: 20101212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.
    Simpson KJ; Dugan AS; Mercurio AM
    Cancer Res; 2004 Dec; 64(23):8694-701. PubMed ID: 15574779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
    van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
    Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
    Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pomegranate fruit extract impairs invasion and motility in human breast cancer.
    Khan GN; Gorin MA; Rosenthal D; Pan Q; Bao LW; Wu ZF; Newman RA; Pawlus AD; Yang P; Lansky EP; Merajver SD
    Integr Cancer Ther; 2009 Sep; 8(3):242-53. PubMed ID: 19815594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells.
    Mukai M; Endo H; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Inoue M
    Biochem Biophys Res Commun; 2006 Jul; 346(1):74-82. PubMed ID: 16750170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line.
    Demou ZN; Awad M; McKee T; Perentes JY; Wang X; Munn LL; Jain RK; Boucher Y
    Cancer Res; 2005 Jul; 65(13):5674-82. PubMed ID: 15994941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
    Guo F; Zheng Y
    Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.
    Pan Q; Bao LW; Teknos TN; Merajver SD
    Cancer Res; 2006 Oct; 66(19):9379-84. PubMed ID: 17018591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
    Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.